Pharmaceuticals and Biotech

Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test

Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test

Universal Diagnostics (UDX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results of an international multicenter observational cohort study: Colorectal cancer detection at 92% sensitivity and 97% specificity was achieved…

MedEvoke Excited to Announce Addition to Content Services Team

MedEvoke Excited to Announce Addition to Content Services Team

MedEvoke, an industry leader in global alignment, offers unique, scientifically compelling narratives and digitally oriented solutions to meet the specific needs of Medical Affairs professionals and leaders in the pharmaceutical industry. Today, MedEvoke is excited to announce the addition of…

Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships

Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships

Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces two senior hires to boost its platform and expand its strategic life science partnerships.Today, Asif Jan and Sezai Taskin bring the Owkin team an…

New Talent at MedEvoke Brings Greater Opportunity for Providing Medical and Scientific Strategy

New Talent at MedEvoke Brings Greater Opportunity for Providing Medical and Scientific Strategy

As an industry leader in global alignment, MedEvoke is positioned to offer unique, scientifically compelling narratives and digitally oriented solutions to overcome the ever-changing needs of Medical Affairs and Clinical Trials professionals. Today, MedEvoke is excited to announce the addition…

PharmaCord Appoints Whitney Mardis to Vice President, Patient Services

PharmaCord Appoints Whitney Mardis to Vice President, Patient Services

PharmaCord LLC, a rapidly growing provider of patient services to life sciences companies, announced today that Whitney Mardis has been promoted to Vice President, Patient Services. In her new role, Ms. Mardis will have full responsibility for a portfolio of patient-support…

UK Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform From Mount Sinai Health System in New York

UK Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform From Mount Sinai Health System in New York

My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a UK-based company, announces an expansion of its licensed technology rights from Mount Sinai Health System. Scientists at the Icahn School of Medicine at Mount Sinai Center for Personalized Cancer Therapeutics (CPCT) in New York…

FDA Law Practice Appoints New Attorney to Further Mission – Milwaukee

FDA Law Practice Appoints New Attorney to Further Mission – Milwaukee

The law firm of Benjamin L. England & Associates, LLC, (http://www.EnglandLawGroup.com) and consulting practice FDAImports.com, LLC, (http://www.fdaimports.com) are pleased to announce that Andrew Harrison has joined the firms to further develop their growing portfolio of national and international clients. Andrew…

Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors

Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors

My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a global leader in personalised cancer therapeutics and in-vivo high throughput drug screening, is pleased to announce the addition of Lilly Wollman to its distinguished board of directors.Lilly Wollman is a seasoned…

Johns Hopkins OpenSpecimen Adoption Over the Years

Johns Hopkins OpenSpecimen Adoption Over the Years

Current Adoption Status: 67 collection protocols / 40+ active usersPublished 67 peer-reviewed articlesSupported 20 grantsManages 400K specimens for 40K study participants100+K specimens sent to Precision Medicine platform*Reference: 2019 OpenSpecimen JHU Annual ReportThe Johns Hopkins University School of Medicine adopted OpenSpecimen…

Climet Announces Introduction of the CI-97 Microbial Air Sampler With Data Integrity and New Advanced Features

Climet Announces Introduction of the CI-97 Microbial Air Sampler With Data Integrity and New Advanced Features

Climet Instruments Company, a Division of Venturedyne Ltd, (herein 'Climet') the leading manufacturer of high quality cleanroom particle counters and microbial samplers, today announced the introduction of their CI-97 microbial air sampler.Climet Instruments Company is very proud to announce the introduction of the…

Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology

Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology

Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited, will announce their partnership at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC), taking place on May 9-11,…

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

EW Healthcare Partners ("EW") has acquired a majority stake in Laboratoires Majorelle ("Majorelle") from its Founders to support its growth and European expansion in line with the Founders' strategy.Headquartered in Paris, Majorelle is a French specialty pharma company focused on…

Are Internet Pharmacies as Safe as Brick-and-Mortar Ones?

Are Internet Pharmacies as Safe as Brick-and-Mortar Ones?

Americans have been hearing about forthcoming changes to the pharmaceutical industry that will work to lower the prices for prescription drugs for years now. There's been little in the way of progress there. There are a host of reasons why…

Nemysis Ltd Announces Appointment of Dr. Margit Holzer to Its Scientific Advisory Board

Nemysis Ltd Announces Appointment of Dr. Margit Holzer to Its Scientific Advisory Board

Nemysis Ltd announced today the appointment of Dr. Margit Holzer to its Scientific Advisory Board (SAB).Dr. Margit Holzer, Scientific Director at Ulysse-Consult Sarl, is a passionate biochemical engineer with internationally recognized expertise in development, industrialization and implementation of biotechnological production processes,…

WholisticResearch Acquires Domain of Adherex Technologies Inc.

WholisticResearch Acquires Domain of Adherex Technologies Inc.

WholisticResearch, the fact-finding blog on rare nootropics and peptides, announced today that it had acquired the domain name previously owned by Adherex Technologies Inc. biopharmaceutical company, committed to discover and develop therapeutics for cancer and cognitive improvement.The CEO of WholisticResearch shared, "I…

GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals

GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals

GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals ("RB&H"), recently merged with Guy's and St Thomas' NHS Foundation Trust ("GSTT"),…

Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability

Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability

Glauconix Biosciences, Inc., leading developer of human 3D ocular tissues, and Nicox SA co-authored, a manuscript in Investigative Ophthalmology and Visual Sciences, demonstrating the IOP lowering ability of NCX 667, a novel nitric oxide donor. These studies were performed using…

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex, a leading international research antibody manufacturer, continues to expand and diversify its nearly comprehensive portfolio of SARS-CoV-2/COVID-19 reagents. Recently, the company has focused on developing products to help overcome the viral variants that threaten to undermine the social distancing…

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti

Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB).Since its inception, Nemysis has initiated and developed high-value innovative R&D programs, including one targeting Celiac Disease and Non-Celiac…

eDeviation the New Protocol Deviations Cloud Software Solution

eDeviation the New Protocol Deviations Cloud Software Solution

Ethical GmbH, the Swiss company providing personalized software solutions for clinical research committees management, has developed a new software solution designed to simplify the protocol deviation (PD) assessment and management process.The new eDeviation®solution will allow clinical trial sponsors, CROs, and EC/IRB…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login